MindSpire, the neurotech start-up dedicated to helping people regulate stress and unlock peak performance, has raised £850,000 in pre-seed funding. This investment will support the launch of MindSpire's first device: SONA^TM, a medical-grade wearable that delivers precision-coded electrical pulses to the vagus nerve, activating brain circuits for calm, focus and enhanced learning.

The round was led by SFC Capital, with participation from SyndicateRoom and non-dilutive innovation funding secured via Innovate UK's Investor Partnership Programme. The £850,000 investment will enable MindSpire, based at the London Institute for Healthcare Engineering (LIHE), to complete the development and launch of SONA^TM.